PolyPid Ltd has a consensus price target of $12 based on the ratings of 5 analysts. The high is $25 issued by BMO Capital on August 11, 2022. The low is $4 issued by Raymond James on September 6, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 14, 2025, December 26, 2024, and December 16, 2024, respectively. With an average price target of $12 between HC Wainwright & Co., there's an implied 389.80% upside for PolyPid Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/14/2025 | Buy Now | 348.98% | HC Wainwright & Co. | Raghuram Selvaraju42% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
12/26/2024 | Buy Now | 348.98% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $11 | Maintains | Buy | Get Alert |
12/16/2024 | Buy Now | 471.43% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
11/04/2024 | Buy Now | 308.16% | Craig-Hallum | Chase Knickerbocker42% | → $10 | Initiates | → Buy | Get Alert |
10/02/2024 | Buy Now | 471.43% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
08/15/2024 | Buy Now | 471.43% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
06/18/2024 | Buy Now | 471.43% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 471.43% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
05/01/2024 | Buy Now | 471.43% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
10/23/2023 | Buy Now | 308.16% | Barclays | Balaji Prasad52% | $2.5 → $10 | Maintains | Equal-Weight | Get Alert |
10/12/2023 | Buy Now | 553.06% | HC Wainwright & Co. | Raghuram Selvaraju42% | → $16 | Initiates | → Buy | Get Alert |
09/07/2022 | Buy Now | 2.04% | Barclays | Balaji Prasad52% | $660 → $75 | Downgrade | Overweight → Equal-Weight | Get Alert |
09/06/2022 | Buy Now | 63.27% | Raymond James | Elliot Wilbur47% | $450 → $120 | Downgrade | Strong Buy → Outperform | Get Alert |
08/11/2022 | Buy Now | 920.41% | BMO Capital | Gary Nachman58% | $810 → $750 | Maintains | Outperform | Get Alert |
The latest price target for PolyPid (NASDAQ:PYPD) was reported by HC Wainwright & Co. on April 14, 2025. The analyst firm set a price target for $11.00 expecting PYPD to rise to within 12 months (a possible 348.98% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for PolyPid (NASDAQ:PYPD) was provided by HC Wainwright & Co., and PolyPid reiterated their buy rating.
There is no last upgrade for PolyPid
The last downgrade for PolyPid Ltd happened on September 7, 2022 when Barclays changed their price target from $22 to $2.5 for PolyPid Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PolyPid, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PolyPid was filed on April 14, 2025 so you should expect the next rating to be made available sometime around April 14, 2026.
While ratings are subjective and will change, the latest PolyPid (PYPD) rating was a reiterated with a price target of $11.00 to $11.00. The current price PolyPid (PYPD) is trading at is $2.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.